Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (141-150 of 974) with videos related to

Pageof 98
Sort By:
Frontiers in Immunology|September 2, 2025
PU.1 upregulation is linked to improved prognosis in non-small cell lung cancerKatja Hohenberger, Denis I Trufa, Arndt Hartmann, et al.
Journal of Cancer Research and Clinical Oncology|July 1, 2018
FOXM1 predicts disease progression in non-muscle invasive bladder cancerSebastien Rinaldetti, Ralph Wirtz, Thomas Stefan Worst, et al.
Histopathology|October 22, 2011
Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre seriesSimone Bertz, Stefan Denzinger, Wolfgang Otto, et al.
Plos One|May 22, 2020
Species-, organ- and cell-type-dependent expression of SPARCL1 in human and mouse tissuesAnika Klingler, Daniela Regensburger, Clara Tenkerian, et al.
Medical Oncology (Northwood, London, England)|April 23, 2017
Prognostic impact of PD-1 and its ligands in renal cell carcinomaFranziska Erlmeier, Wilko Weichert, Andres Jan Schrader, et al.
International Journal of Cancer|July 22, 2009
No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancerWolfgang Otto, Stefan Denzinger, Simone Bertz, et al.
World Journal of Urology|May 6, 2015
Loss of AQP3 protein expression is associated with worse progression-free and cancer-specific survival in patients with muscle-invasive bladder cancerPeter Rubenwolf, Christian Thomas, Stefan Denzinger, et al.
Cancers|September 25, 2019
CD8+ and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck CancerAlessia Echarti, Markus Hecht, Maike Büttner-Herold, et al.
Histopathology|May 4, 2012
The many faces of acinic cell carcinomas of the salivary glands: a study of 40 cases relating histological and immunohistological subtypes to clinical parameters and prognosisStephan Schwarz, Johannes Zenk, Maximilian Müller, et al.
Histopathology|August 15, 2017
Large nested variant of urothelial carcinoma: a clinicopathological study of 36 casesEva Compérat, Jesse K McKenney, Arndt Hartmann, et al.
Pageof 98

Showing results (141-150 of 974) with videos related to

Sort By:
Pageof 98
Frontiers in Immunology|September 2, 2025
PU.1 upregulation is linked to improved prognosis in non-small cell lung cancerKatja Hohenberger, Denis I Trufa, Arndt Hartmann, et al.
Journal of Cancer Research and Clinical Oncology|July 1, 2018
FOXM1 predicts disease progression in non-muscle invasive bladder cancerSebastien Rinaldetti, Ralph Wirtz, Thomas Stefan Worst, et al.
Histopathology|October 22, 2011
Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre seriesSimone Bertz, Stefan Denzinger, Wolfgang Otto, et al.
Plos One|May 22, 2020
Species-, organ- and cell-type-dependent expression of SPARCL1 in human and mouse tissuesAnika Klingler, Daniela Regensburger, Clara Tenkerian, et al.
Medical Oncology (Northwood, London, England)|April 23, 2017
Prognostic impact of PD-1 and its ligands in renal cell carcinomaFranziska Erlmeier, Wilko Weichert, Andres Jan Schrader, et al.
International Journal of Cancer|July 22, 2009
No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancerWolfgang Otto, Stefan Denzinger, Simone Bertz, et al.
World Journal of Urology|May 6, 2015
Loss of AQP3 protein expression is associated with worse progression-free and cancer-specific survival in patients with muscle-invasive bladder cancerPeter Rubenwolf, Christian Thomas, Stefan Denzinger, et al.
Cancers|September 25, 2019
CD8+ and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck CancerAlessia Echarti, Markus Hecht, Maike Büttner-Herold, et al.
Histopathology|May 4, 2012
The many faces of acinic cell carcinomas of the salivary glands: a study of 40 cases relating histological and immunohistological subtypes to clinical parameters and prognosisStephan Schwarz, Johannes Zenk, Maximilian Müller, et al.
Histopathology|August 15, 2017
Large nested variant of urothelial carcinoma: a clinicopathological study of 36 casesEva Compérat, Jesse K McKenney, Arndt Hartmann, et al.
Pageof 98